器官移植2025，Vol.16Issue(3)：379-385,7.DOI:10.12464/j.issn.1674-7445.2025087
2024年中国肺移植临床研究年度盘点
Annual review of clinical research on lung transplantation of China in 2024
摘要
Abstract
Lung transplantation is currently the only recognized effective treatment for end-stage lung disease and has improved the quality of life for patients.However,lung transplantation still faces many challenges,including rejection,infection,post-transplant acute kidney injury,post-transplant diabetes mellitus,ischemia-reperfusion injury and donor shortage,etc.Chinese lung transplantation scholars made a series of important progress in the field of clinical research in 2024,focusing on the study and solution of the above problems,and providing new ideas for lung transplantation surgery.This article systematically reviews the clinical research and technological innovation in the field of lung transplantation in 2024,summarizes the achievements of clinical research in the field of lung transplantation in China in 2024,and aims to providing new directions and strategies for future research.关键词
肺移植/排斥反应/感染/急性肾损伤/缺血-再灌注损伤/体外膜肺氧合/移植后糖尿病/供者短缺Key words
Lung transplantation/Rejection/Infection/Acute kidney injury/Ischemia-reperfusion injury/Extracorporeal membrane oxygenation/Post-transplant diabetes mellitus/Donor shortage分类
临床医学引用本文复制引用
靳小汉,孙艺馨,马吉尔,喻赠玮,刘亚灵,侯森林,郑翔匀,严浩吉,田东..2024年中国肺移植临床研究年度盘点[J].器官移植,2025,16(3):379-385,7.基金项目
国家自然科学基金(82470104) （82470104）
